Medication info

Zincline Injection (Zinc Sulfate Hydrate)

Prescription medicationInjections
Ingredient · strength
Zinc Sulfate Hydrate›4.4mg / 1mL
Manufacturer / importer
Samjin Pharmaceutical Co., Ltd.
Appearance
A colorless and odorless transparent solution contained in a colorless transparent vial injection.
Packaging
5mL-10 vials/box, 10mL-10 vials/box, 20mL-10 vials/box
Approval status
Active

MFDS item code 201405970 · Notified 2014.12.19

Summary

Main use
Prevention of zinc deficiency during parenteral nutrition (TPN)
Who uses it
Adults · Children
Adult dosage
Use as prescribed by a physician, checking plasma trace element levels to guide dosage adjustment. Metabolically stable patients receiving TPN: 2.5 ∼ 4 mg/day Adult patients with small-intestinal fluid losses: an additional 12.2 mg/L (volume of fluid loss) or an additional 17.1 mg/kg (amount excreted) Acute catabolic state: 4.5 ∼ 6 mg/day
Children's dosage
Children 5 years and younger: 100 ug/kg/day Premature infants weighing 3 kg or less: 300 ug/kg/day

Ingredients

Manufacturer
Samjin Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention of zinc deficiency during parenteral nutrition (TPN)

View approved original text

It is important to supplement zinc to prevent zinc deficiency in patients receiving Total Parenteral Nutrition (TPN). Zinc is an essential mineral for immune function and wound healing, and deficiency can occur in TPN patients. Therefore, suitable zinc supplementation improves nutritional status and prevents complications. It is used to support the overall health of patients by supplementing zinc.

Dosage and Administration

Adult dosage

Use as prescribed by a physician, checking plasma trace element levels to guide dosage adjustment. Metabolically stable patients receiving TPN: 2.5 ∼ 4 mg/day Adult patients with small-intestinal fluid losses: an additional 12.2 mg/L (volume of fluid loss) or an additional 17.1 mg/kg (amount excreted) Acute catabolic state: 4.5 ∼ 6 mg/day

Children's dosage

Children 5 years and younger: 100 ug/kg/day Premature infants weighing 3 kg or less: 300 ug/kg/day

Precautions

This medication must be diluted before administration; administering it directly into the peripheral vein can cause phlebitis or kidney damage due to zinc. Toxic symptoms from this drug are rarely observed because the zinc content is very low. When mixing this drug with Total Parenteral Nutrition (TPN) solutions, it is advisable to work in a laminar airflow environment to maintain sterility. Before administration, visually check that the injectable medication is free from any precipitates or discoloration. Since administration of zinc can decrease copper levels, plasma concentrations of copper and zinc should be regularly checked to inform dosing adjustments. This drug is excreted through the intestines and kidneys; caution is needed in patients with impaired excretory functions as zinc may accumulate in the body. The safety of this drug in pregnant women or women who may become pregnant has not been established; it should only be administered when the therapeutic benefit outweighs the risk. Zinc crosses the placenta and can be present in breast milk; therefore, pregnant and breastfeeding women should consult a healthcare professional before use. In case of overdose, symptoms such as nausea, vomiting, dehydration, electrolyte imbalance, dizziness, abdominal pain, drowsiness, and ataxia may occur, necessitating caution. Calcium intake may help protect against zinc toxicity. Keep out of reach of children and store in a dry place at room temperature in the original packaging. This medication does not contain preservatives, so any unused portion must be disposed of properly.

Side effects

Phlebitis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent air exposure, and it is recommended to keep it at a temperature between 1°C and 30°C at room temperature. This helps maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

A colorless and odorless transparent solution contained in a colorless transparent vial injection.

Package unit

5mL-10 vials/box, 10mL-10 vials/box, 20mL-10 vials/box

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.